Synaptic defects in type I spinal muscular atrophy in human development.
about
Small molecule suppressors of Drosophila kinesin deficiency rescue motor axon development in a zebrafish model of spinal muscular atrophySelective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense OligonucleotidesRequirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles.Presynaptic localization of Smn and hnRNP R in axon terminals of embryonic and postnatal mouse motoneuronsSpinal muscular atrophy: journeying from bench to bedsideSplicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins.Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project.Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.Decreased function of survival motor neuron protein impairs endocytic pathways.The DcpS inhibitor RG3039 improves motor function in SMA mice.Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy.Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?Neurodegeneration in spinal muscular atrophy: from disease phenotype and animal models to therapeutic strategies and beyond.Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.Spectrum of neuropathophysiology in spinal muscular atrophy type IThe Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?Neuroprotective Effect of Non-viral Gene Therapy Treatment Based on Tetanus Toxin C-fragment in a Severe Mouse Model of Spinal Muscular AtrophyDissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysisAtrial Septal Defect, Neuromuscular Junction and Skeletal Abnormalities in Spinal Muscular Atrophy Type IIIThe craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy.Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy.Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.A continuous repetitive task to detect fatigability in spinal muscular atrophy
P2860
Q28536678-717BAAC1-0095-4E3B-89FF-2998CA316836Q28551647-724EAFD4-210E-41AE-9022-C49DECC93917Q30569780-29B583C0-4155-4EFB-8F1B-B3716E196B88Q33638307-075A6851-4DE4-4208-ACD5-C38B6094B7A6Q33997358-7E0D9B08-65D4-477A-BCE0-D2D0F5A040C7Q34388403-413A823C-E861-41AD-A834-FE223950EFD4Q35340133-081D1290-C393-49F9-9988-E76542A490D2Q35563254-3F403F71-9758-40B8-B8F9-D131ED17F443Q35824759-4276A999-BB35-4EA1-A30D-C4EAA6A1DA50Q36061996-C7265FD5-0B51-4398-994B-5E1A6E98E694Q36293324-9BCE0A9D-5822-45EE-A66A-5B1F9D7BEFD4Q37142721-CAFB0237-13BB-4083-B686-A55792E48E86Q37193900-18C37926-0C7B-44AF-839B-BD0035A48323Q37353218-D81B2105-6A37-4F20-8A41-6BD31E7EC852Q38123249-6E4FE61E-A743-4C8D-8F90-5DB050CB6CC1Q38197609-2E579BF3-ADCF-4291-9EE5-9C53B249C83BQ38896015-5AC0F88A-A7E0-4DA8-BBB1-733FFBB26CD0Q39084725-B1FFFEDB-60B4-40AE-B145-62F71E4AC23CQ39274901-A040F103-FFCD-45A6-BC77-2B08E78F8047Q40590397-4F17B0FD-81A2-4056-B2C9-081AC8503F86Q42066491-8A1F0EBA-D15D-4C1A-9432-47B2885F6A6BQ42267318-687712A2-10AA-4830-8CF8-155BC327EB21Q42439185-3BFA9EB7-8F35-4C19-B3FE-4C412FFE65D0Q43601070-9810E38A-508F-4731-95A3-93980B4A8DD1Q48229331-BCCDD80C-4A65-442D-8F42-6349CA064A18Q49304342-45FB39F5-FAFF-45E5-B6B5-2C5656ECABE9Q51148309-D05A03C1-03B4-48CC-985A-84B99765B5D3Q58748704-F34AB8AB-D939-4DA4-93F5-043FB274C330
P2860
Synaptic defects in type I spinal muscular atrophy in human development.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Synaptic defects in type I spinal muscular atrophy in human development.
@en
Synaptic defects in type I spinal muscular atrophy in human development.
@nl
type
label
Synaptic defects in type I spinal muscular atrophy in human development.
@en
Synaptic defects in type I spinal muscular atrophy in human development.
@nl
prefLabel
Synaptic defects in type I spinal muscular atrophy in human development.
@en
Synaptic defects in type I spinal muscular atrophy in human development.
@nl
P2093
P2860
P356
P1476
Synaptic defects in type I spinal muscular atrophy in human development.
@en
P2093
Eduardo F Tizzano
Eva Also-Rallo
Josep E Esquerda
Laura Alías
Marta Hereu
María Jesús Barceló
Rebeca Martínez-Hernández
Sara Bernal
P2860
P356
10.1002/PATH.4080
P577
2013-01-01T00:00:00Z